-+ 0.00%
-+ 0.00%
-+ 0.00%

HSBC Maintains Buy on AbbVie, Raises Price Target to $315

Benzinga·09/10/2026 14:10:43
Listen to the news
HSBC analyst Rajesh Kumar maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $300 to $315.